In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon, PA-C, welcomes Jessica Glennie, CNP, to continue their 2026 EULAR ILD RhAPP Up series by reviewing the latest research on systemic sclerosis-associated interstitial lung disease (SSc-ILD) and progressive pulmonary fibrosis (PPF).

The discussion highlights new real-world data showing that many patients with early SSc-ILD maintain stable lung function when closely monitored and treated appropriately. The episode also explores the safety and tolerability of an emerging antifibrotic therapy, reviewing its potential role in slowing disease progression while offering a favorable side effect profile for patients with autoimmune-related lung disease.

Whether you're a rheumatology provider, advanced practice provider (APP), or other healthcare professional, this episode delivers practical insights into early disease monitoring, evolving treatment options, and strategies to help improve long-term outcomes for patients with ILD.

Stay tuned for Part 3 and visit the Content Rheum to stay up to date with the latest clinical insights in rheumatologic care.